期刊文献+

普罗布考胶束给药系统的制备及口服淋巴吸收评价 被引量:2

Preparation and evaluation of oral lymphatic absorption of probucol-loaded micelle delivery system
原文传递
导出
摘要 目的研究一种可促进普罗布考口服淋巴吸收的胶束给药系统。方法使用甲氧基聚乙二醇磷脂酰乙醇胺(mPEG-DSPE)作为载体材料,制备载普罗布考胶束给药系统并进行优化,并通过清醒大鼠淋巴插管模型评价其提高药物口服淋巴转运的作用。结果经处方优化以后,以mPF^DSPE作为载体材料制备的载普罗布考胶束的包封率>90%。清醒大鼠淋巴插管模型考察结果表明,载药胶束8 h内的淋巴转运药物累积量约为混悬组的3倍。结论 mPEC-DSPE胶束给药系统可显著提高普罗布考的淋巴转运量。 AIM To develop a drug-loaded micelle formulation which could enhance the oral lymphatic absorption of probucol. METHODS mPEG-DSPE was chosen to prepare the micelle by film formation method. Conscious rat model was chosen for the in vivo evaluation of the micelle. RESULTS Encapsulated efficiency of probucol in the miceUe was higher than 90%. Probucol transported by lymph in 8 h after administration in drug-loaded micelle group was three times than that from probucol suspension group. CONCLUSION mPEG-DSPE based miceUe could significantly improve the lymphatic absorption of probucol.
出处 《中国临床药学杂志》 CAS 2012年第2期83-87,共5页 Chinese Journal of Clinical Pharmacy
关键词 普罗布考 胶束 口服淋巴吸收 probucol micelle oral lymphatic absorption
  • 相关文献

参考文献2

二级参考文献9

  • 1Barnhart JW,Sefranka JA,McIntosh DD.Hypocholesterolemic effect of 4,4′-(isopropylidenedithio)-bis(2,6-di-t-butylphenol)(probucol) [J].Am J Clin Nutr,1970,23(9):1229-1233.
  • 2Heel RC,Brogden RN,Speight TM,et al.Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolemia [J].Drugs,1978,15(6):409-428.
  • 3Buckley MM,Goa KL,Price AH,et al.Probucol.A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolemia [J].Drugs,1989,37(6):761-780.
  • 4Schwartz CJ.Introduction the probucol experience: a review of the past and a look at the future [J].Am J Cardiol,1988,62(3):1B-5B.
  • 5Matsuzawa Y,Yamashita S,Funahashi T,et al.Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper HDL2 cholesterolemia with abnormal cholesteryl ester transfer [J].Am J Cardiol,1988,62(3):66B-72B.
  • 6Schneider JE,Berk BC,Gravanis MB,et al.Probucol decreases neointimal formation in a swine model of coronary artery balloon injury [J].Circulation,1993,88(2):628-637.
  • 7Kudo S,Akiyama H,Odomi M,et al.High-performance liquid Chromatographic procedure for the determination of probucol in human plasma [J].J Chromatogr,1983,277(2):419-422.
  • 8Jaffar NZ,Nitin KG,Louise AF,et al.Measurement of plasma probucol levels by high-performance liquid chromatography [J].J Chromatogr Biomed,1994,654(1):55-60.
  • 9Huang SK,Han KQ.Several statistical approaches to bioequivalence assessement [J].Chin J Clin Pharmacol (中国临床药理学杂志),1993,9(1):43-46.

共引文献22

同被引文献27

  • 1付亭亭,左文宝,郭珏铄,杨建宏.固体分散体的释药机制及其物理稳定性研究进展[J].中国新药杂志,2020,29(3):275-280. 被引量:21
  • 2齐晓丹,曹德英.普罗布考固体分散体的制备及体内评价[J].中国医药工业杂志,2005,36(8):483-486. 被引量:5
  • 3Keating GM, Croom KF. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus[J]. Drugs, 2007, 67(1 ) : 121-153.
  • 4Jette KK, Law D, Sehmitt EA, et al. Preparation and drug loading of poly( ethylene glycol)-bloek-poly(caprolactone) micelles through the evaporation of a cosolvent azeotrope [ J ]. Pharm Res, 2004,21 (7) : 1184-1191.
  • 5Granero GE, Ramaehandran C, Amidon GL. Dissolution and solubil- ity behavior of fenofibrate in sodium lanryl sulfate solutions [ J ]. Drug Dev lnd Pharm, 2005, 31(9): 917-922.
  • 6Tran TH, Ramasamy T, Truong DH, et al. Preparation and charac- terization of fenofibrate-loaded nanostruetured lipid carriers fro" oral bioavailability enhaneernent[ J ]. AAPS PharmSciTech, 2014, 15 (6) : 1509-1515.
  • 7Kedar U, phutane P, Shidhaye S, et al. Advances in polymeric mi- eelles for drug delivery and tumor targeting [ J ]. Nanomedicine, 2010, 6(6) : 714-729.
  • 8Yuan H, Lu LJ, Du YZ, et al. Stearic acid-g-chitosan polymeric mi- celle for oral drug delivery: In vitro transport and in vivo absorption I J]. Mol Pharm, 2010, 8 (1): 225-238.
  • 9Wang Y, Chen L, Tan L, et al. PEG-PCL based micelle hydrogels as cral docetaxel delivery systems for breast cancer therapy [J]. Bio- materials, 2014, 35(25): 6972-6985.
  • 10Gancher G, Satturwar P, Jones MC, et al. Polymeric micelles for oral drug delivery [ J ]. Eur J Pharm Biopharm, 2010, 76 (2) : 147-158.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部